Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | THPO | P40225 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9639947 | 1.00 | — | — | |
| SCHEMBL17027943 | 1.00 | CA1 (0.36) | CA1CA2CA9ACHETSHR | |
| SCHEMBL2009308 | 1.00 | CA1 (0.36) | CA1CA2CA9ACHETSHR | |
| SCHEMBL730619 | 1.00 | — | — | |
| Water SCHEMBL303842 | 0.95 | CA1 (0.33) | CA1CA2CA9 | |
| Water SCHEMBL7785499 | 0.95 | — | — | |
| Water SCHEMBL60219 | 0.95 | — | — | |
| Water SCHEMBL9137493 | 0.95 | — | — | |
| Bicarbonate SCHEMBL21796223 | 0.95 | CA1 (0.46) | CA1CA2CA9 | |
| SCHEMBL678902 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0851913-A1 | NOVEL LIPOLYTIC ENZYMES | NOVO NORDISK A/S (DK) | 1998-07-08 | — | — | EP | disclosed |
| WO-1997007202-A1 | NOVEL LIPOLYTIC ENZYMES | NOVO NORDISK A/S (DK) | 1997-02-27 | — | — | WO | disclosed |
| WO-1997004078-A1 | A MODIFIED ENZYME WITH LIPOLYTIC ACTIVITY | NOVO NORDISK A/S (DK) | 1997-02-06 | — | — | WO | disclosed |